Frazier William 4

What Happened

• William Frazier, Chief Medical Officer and director of Viemed Healthcare (VMD), had restricted/phantom share units vest/settle on January 21, 2026. The filing reports conversions/exercises of 3,401 and 850 derivative units (total 4,251 units).
• As part of the vesting/settlement, 1,169 shares were withheld by the issuer to satisfy tax withholding and 850 shares were disposed back to the issuer (total 2,019 shares disposed), at a reported per‑share value of $7.49, producing cash of $8,756 and $6,367 respectively (total ~$15,123).
• These actions reflect vesting and settlement (RSUs and cash‑settled phantom shares), not open‑market purchases or sales.

Key Details

• Transaction date: January 21, 2026; Form 4 filed January 23, 2026 (filed two days after the transactions).
• Reported prices/values: per‑share market closing price used = $7.49 (footnote F3); cash proceeds from withheld/sold shares = $8,756 + $6,367 = $15,123.
• Shares withheld/sold: 1,169 shares withheld for taxes (F2); 850 shares disposed to issuer for cash (D).
• Instruments and codes: M = exercise/conversion of derivative units (RSUs/phantom units); F = shares withheld to cover tax obligation; D = disposition to issuer (cash settlement) (see footnotes F1–F6).
• Shares owned after transaction: not specified in the excerpt of the filing provided.

Context

• The filing combines RSU vesting (each RSU = 1 common share per F1 & F5) and settlement of phantom share units that are cash‑settled (F4 & F6). For the phantom units, the filing reports both the acquisition of underlying shares and the simultaneous disposition of those shares back to the company for cash (cash settlement).
• This is a vesting/settlement event and tax withholding/cash settlement rather than an open‑market sale; such internal settlements are common when equity awards vest.